Successful treatment of methicillinresistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2186-2188

  Joson, Jeremiah ^a   Grover, Casey ^b,d   Downer, Caitlin ^c,e   Pujar, Thejeswi ^a,f   Heidari, Arash ^a  

^a KERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e ARROWHEAD REGIONAL MEDICAL CENTER   (United States)

^f Allen College   (United States)

Author keywords

DNSSA; Intravenous drug user; Mitral annuloplasty; Salvage therapy

Indexed keywords

DAPTOMYCIN; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; TELAVANCIN; VANCOMYCIN; ACETAMIDE DERIVATIVE; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; BACTERIAL ENDOCARDITIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; FEVER; HUMAN; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MITRAL ANNULOPLASTY; MITRAL VALVE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RIGOR; TACHYCARDIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PARAPLEGIA; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE;

ACETAMIDES; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MITRAL VALVE; OXAZOLIDINONES; PARAPARESIS; STAPHYLOCOCCAL INFECTIONS; TREATMENT FAILURE;

EID: 80051702708     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr234     Document Type: Letter

References (6)

1. Jang HC, Kim SH, Kim KH et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis 2009; 49: 395-401.
2. Attwood RJ, LaPlante KL. Telavancin: a novel lipoglycopeptide antimicrobial agent. Am J Health Syst Pharm 2007; 64: 2335-48.
3. Rybak M, Lomaestro B, Rotschafer JC et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-Systems Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66: 82-98.
4. Moise PA, North D, Steenbergen JN et al. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 2009; 9: 617-24.
5. MarcosLA, CaminsBC. Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin. Antimicrob Agents Chemother 2010; 54: 5376-8.
6. Cunha BA, Pherez FM. Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE). Eur J Clin Microbiol Infect Dis 2009; 28: 831-3.